|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Deferred offering costs | ||||||||
| Cash | ||||||||
| Other receivable | ||||||||
| Related Party | ||||||||
| Total other receivable | ||||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Investments held in trust account | ||||||||
| Total Assets | ||||||||
| Liabilities, Shares Subject to Redemption and Shareholders’ Equity | ||||||||
| Accrued offering costs | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Promissory note - related party | ||||||||
| Total current liabilities | ||||||||
| Total Liabilities | ||||||||
| Class A ordinary shares subject to possible redemption, no par value; 100,000,000 shares authorized; 282,581 shares issued and outstanding at redemption value of $10.73 per share and 282,581 shares issued and outstanding at redemption value of $10.55 per share as of June 30, 2026 and December 31, 2025, respectively | ||||||||
| Shareholders’ Equity: | ||||||||
| Additional paid-in capital | ||||||||
| Retained earnings | ||||||||
| Total shareholders’ equity | ||||||||
| Total Liabilities, Shares Subject to Redemption and Shareholders’ Equity |
Loading...
